Skip to main content
. 2019 Aug 13;11(8):411. doi: 10.3390/pharmaceutics11080411
API Active pharmaceutical ingredient
AUC Area under the concentration-time curve
BBB Blood-brain barrier
BCS Biopharmaceutics classification system
CM Carrier-mediated
Cmax Maximum concentration
F Bioavailability
Fabs Fraction absorbed
FDA US Food and Drug Administration
GI Gastrointestinal
HBD Hydrogen bond donor
MR Modified-release
OrBiTo Innovative Tools for Oral Biopharmaceutics
Peff Effective permeability
PBPK Physiologically based pharmacokinetic
QSAR Quantitative structure-activity relationship
SPIP Single-pass intestinal perfusion